e-ISSN: Pending
Negative / Null Result ReportOpen accessPediatrics

Mycophenolic acid trough level assessment in patients with lupus nephritis; does it make a difference?

Ahmed E. Abdulgalil; Noha H. Elnagdy; Nehal M. Ramadan; Eman Hamza; Ayman Hammad; Mai S Korkor; Atef Elmougy; Ali Sobh · 2025 · Pediatric Rheumatology Online Journal

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Abstract Introduction Mycophenolate Mofetil (MMF) has become one of the cornerstone treatments of lupus nephritis (LN). It is converted into mycophenolic acid (MPA), an active metabolite, that displays high inter- and intra-individual pharmacokinetic variability. However, the routine monitoring of MPA trough level is still debatable. Objectives The present study aims to evaluate the relationship between MPA trough levels and both clinical outcomes and drug-related adverse effects during the maintenance phase of LN in Egyptian patients. Methods We included thirty-five adults and twenty-nine chi

Abstract by Ahmed E. Abdulgalil; Noha H. Elnagdy; Nehal M. Ramadan; Eman Hamza; Ayman Hammad; Mai S Korkor; Atef Elmougy; Ali Sobh, Pediatric Rheumatology Online Journal (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1186/s12969-025-01074-7